1564-1565 / 1676
Radiomics
model HPV predictions vs molecular
assay p16
0
10
20
30
40
50
60
0.0
0.2
0.4
0.6
0.8
1.0
**
* * *
* * * *
*
** * *
* *
*
*
* * * ***
**
* * * * * * ** **** ** ***
0
**
* *
*
* * *
* *
* *
*
*
* **
** * *
* * * *** ** ** *
M
all
p16
HPV-
HPV+
HPV predictions by M
all
vs. HPV by p16
0
10
20
30
40
50
60
0.0
0.2
0.4
0.6
0.8
1.0
**
*
* * * *
*
* * * * * * *
* ** * **
*
* * ** *
*
* *
** *** *
** **
**
* *
* * * * * * * * **
* *
*
*
*
* **
* * *
* * *
* * * *** * ** ***
M
no art
p16
HPV-
HPV+
HPV predictions by M
no art
vs. HPV by p16
a
b
p<0.05
p<0.05
Consistent and significant split between survival curves for HPV+ and
HPV- determined by p16, M
all (including CT dental artefecats)
and M
no art
Leijenaar et al., Unpublished